Abstract
Diabetes, Obesity and MetabolismVolume 1, Issue 6 p. 317-322 Metabolic effects of moxonidine and other centrally acting antihypertensives Michael Schachter, Michael Schachter Department of Clinical Pharmacology and Therapeutics, Imperial College School of Medicine, St Mary’s Hospital, London, UKSearch for more papers by this author Michael Schachter, Michael Schachter Department of Clinical Pharmacology and Therapeutics, Imperial College School of Medicine, St Mary’s Hospital, London, UKSearch for more papers by this author First published: 25 December 2001 https://doi.org/10.1046/j.1463-1326.1999.00042.xCitations: 6 Dr M. Schachter, Department of Clinical Pharmacology, St Mary’s Hospital, London W2 1NY, UK. E-mail:M.Schachter@ic.ac.uk Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onFacebookTwitterLinked InRedditWechat Citing Literature Volume1, Issue6November 1999Pages 317-322 RelatedInformation
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
